{"schema_version":"secwatch.filing_event.v1","accession":"0001740797-24-000015","form_type":"8-K","ticker":"AVAI","cik":"0001740797","company_name":"AVAI BIO, INC.","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.843989+00:00","generated_at":"2026-06-03T06:35:23.535351+00:00","sec_items":["1.01","3.02","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Avant Technologies CEO & COO resign; William Hisey named Interim CEO","bullets":["Timothy Lantz resigned as CEO and Director effective April 24, 2024, without conflicts with the Board.","Angela Harris resigned as COO and Jared Pelski as VP Business Development, effective April 24, 2024.","William Hisey appointed Interim CEO effective April 25, 2024; base salary $4,000/month plus quarterly RSA of 70,000 shares.","All three prior employment agreements (Lantz, Pelski, Harris) canceled by mutual consent; no claims outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001740797-24-000015","json":"https://secwatch.observer/filing/0001740797-24-000015.json","markdown":"https://secwatch.observer/filing/0001740797-24-000015.md","text":"https://secwatch.observer/filing/0001740797-24-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/avai8k_.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:35:23.535351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11a8f35036","claim":"Timothy Lantz resigned as Director at AVAI BIO, INC..","evidence_excerpt":"Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"641af19064","claim":"Jared Pelski resigned as Vice President – Business Development at AVAI BIO, INC..","evidence_excerpt":"Effective April 24, 2024, Jared Pelski resigned as Vice President – Business Development of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Vice President – Business Development"}],"fact_type":"executive_change"},{"claim_id":"884604b38a","claim":"Timothy Lantz resigned as Chief Executive Officer at AVAI BIO, INC..","evidence_excerpt":"Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"f704b4586a","claim":"William Hisey was appointed as Interim Chief Executive Officer at AVAI BIO, INC..","evidence_excerpt":"William Hisey – Interim CEO Appointment: On April 24, 2024, Avant Technologies, Inc. (the 'Company') and William Hisey entered into an Employment Agreement pursuant to which Mr. Hisey was retained as Interim Chief Executive Officer ('CEO').","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"fb548886ea","claim":"Angela Harris resigned as Chief Operating Officer at AVAI BIO, INC..","evidence_excerpt":"Effective April 24, 2024, Angela Harris resigned as Chief Operating Officer ('COO') of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}